CClinicalTrials.gg
RecruitingNCT06933303DISTRACTUpdated Apr 18, 2025

Distraction as Treatment for Pain in Children in Resource-scarce Settings

An interventional study of Distraction with kaleidoscope in Pain, Acute, sponsored by Vrinnevi Hospital. Recruiting at 1 site in South Africa. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Vrinnevi Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

Pain alleviation in pediatric patients can be challenging for medical professionals working in resource scarce settings due to limited availability of medication, monitoring equipment, or training in this field of expertise. This poses the need for a readily available tool for pain reduction that does not rely on expensive equipment or medication and which can easily be applied in resource scarce settings around the world. With this research project we aim to assess the effectiveness of a simple, inexpensive, non-electronic distraction method: a kaleidoscope, to reduce acute pain in pediatric patients undergoing dressing changes in resource scarce environments.

A randomized controlled trial will be performed at the Edendale Hospital in Pietermaritzburg KwaZulu Natal, South Africa. Pediatric patients between the age of 7-12 years with partial thickness burn injuries who require dressing changes in the outpatient clinic will be randomized into two groups: one group (control) will receive standard practice of care which concerns a dressing change without any pain alleviation other than paracetamol or a non-steroidal anti inflammatory drug (NSAID), and one group (intervention) will receive distraction by use of a kaleidoscope as method for potential pain alleviation on top of standard medical care. The primary outcome will be the difference in mean change in pain score (from before to during the dressing change) between the control and distraction group.

This study is expected to demonstrate that the use of a non-electronic distraction technique effectively alleviates pain in children undergoing dressing changes and that its use is feasible in low resource settings. The distraction technique can be applied as add-on to pharmacological treatment, or stand-alone when no pharmacological treatment is available. Distraction is expected to be safe and can even be applied by an accompanying parent, resulting in lower barriers for healthcare workers to apply it. Appropriate pain relief will improve psychological wellbeing of pediatric patients undergoing painful procedures, and it might even improve recovery and physical rehabilitation since pain has been associated with physical as well as mental morbidity.

02

Conditions studied

  • Pain, Acute

Browse trials for

Keywords

  • Distraction
  • Pain
  • Burn injury
  • Dressing change
  • Pediatric
03

In context

Acute Pain

876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.

This study's planned enrollment of 126 is above the median of 90 across 732 interventional studies indexed under Acute Pain.

Browse Acute Pain studies →

Lead sponsor

Vrinnevi Hospital is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pediatric patients between the age of 7 and 12 years old with burn injuries requiring dressing changes in the outpatient clinic, who in regular practice (non-research setting) would not receive any analgesics;
  • Type of burn injury: partial thickness burns with a burned area not greater than 10% at the moment of the first dressing change measurement as part of this research

Exclusion criteria

Exclusion Criteria:

  • Patients who received split skin grafts for their burns;
  • Patients on sedatives or anti-epileptics;
  • The use of pain-relieving medication other than paracetamol or ibuprofen;
  • Painful additional injuries other than the burn injury;
  • Patients who are nursed in isolation;
  • Physical or mental impairments which make it impossible to adequately comply with the trial protocol. For example, visual impairments, impaired ability to communicate, psychological comorbidities, and burns that limit the use of a kaleidoscope (facial burns or burns to both hands);
  • Retrospective exclusion if the patient in the intervention group did not look through the kaleidoscope for more than 50% of the procedure time.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
126 participants (estimated)

Study arms

  • No intervention
    Control

    Undergoing dressing change with standard medical care. Standard medical care can include: no pain alleviation methods; paracetamol; non-steroidal anti-inflammatory drug; combination of paracetamol with non-steroidal anti-inflammatory drug

  • Experimental
    Distraction

    Undergoing dressing change with standard medical care (as described above for Control arm), combined with distraction by use of a kaleidoscope as a possible pain alleviation method.

    Device: Distraction with kaleidoscope

Interventions

  • DeviceDistraction with kaleidoscope

    During the intervention measurement, the pediatric patient will be distracted by the use of a kaleidoscope during the procedure. Distraction by use of the kaleidoscope will be initiated at the start of the procedure (dressing change) and the kaleidoscope will be offered until at least a minute after the procedure is completed. Removal of the dressing will be started when the child seems distracted as indicated by response with a smile or laughter, or a verbal response

06

What researchers measure

Primary outcomes

  1. Change in pain score

    The change (increase) in pain scores (the Wong-Baker FACES Pain Rating Scale and the FLACC scale), 0 (less pain)-10 (more pain) , from prior to the dressing change to during the dressing change

    Time frame: Pain scores measured five minutes prior to dressing change; pain score during dressing change, measured immediately after removal of the dressing

Secondary outcomes

  1. Postprocedural pain score decrease

    Change in mean pain scores (the Wong-Baker FACES Pain Rating Scale and the FLACC scale), 0 (less pain)-10 (more pain) , when comparing scores during with scores after the procedure.

    Time frame: Pain scores during dressing change, after removal of the dressing; pain score at five minutes after dressing change

  2. Heart rate

    Change/course of heart rate before, during and after dressing change

    Time frame: Measured five minutes before dressing change; measured during dressing change at two-minute interval; measured five minutes after dressing change

  3. Oxygen saturation

    Change/course of blood oxygen levels before, during and after dressing change

    Time frame: Measured five minutes before dressing change; measured during dressing change at two-minute interval; measured five minutes after dressing change

  4. Global satisfaction

    Global judgement of satisfaction with treatment by caregiver and medical professional, will be measured on a 1 (very dissatisfied)-5 (very satisfied) scale based on the question: "Considering pain relief, side effects, and emotional status, how satisfied were you with the dressing change the child underwent?"

    Time frame: Five minutes after dressing change

  5. Procedure time

    Procedure time (seconds), reflecting procedure efficiency/patient cooperation

    Time frame: Duration of dressing change

07

Study locations

1 of 1 sites recruiting
  • Ngwelezana Hospital
    Empangeni, Kwazulu Natal 3880, South Africa
    • Ravi Naidoo, MD, PhD · Contact · ravi@drnaidoo.co.za · +27359017000
    • Ravi Naidoo, MD, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06933303
Lead sponsor
Vrinnevi Hospital
Collaborators
Radboud University Medical Center, Linkoeping University, University of KwaZulu
Responsible party
Måns Muhrbeck MD, PhD (Principal investigator, Vrinnevi Hospital) — Principal investigator
First posted
Apr 18, 2025
Start date
Mar 30, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 18, 2025

Study contacts

Måns Muhrbeck Senior surgical consultant, MD, PhD
Contact
mans.muhrbeck@liu.se
46-703338852

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion